A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer.
Chiusolo P, Marchetti C, Rossi M, Minnella G, Salutari V, Distefano M, Giammarco S, Metafuni E, Minucci A, Frioni F, Gasbarrino C, Colangelo M, Orteschi D, Fagotti A, Lorusso D, Pagano L, De Stefano V, Scambia G, Sica S.
Chiusolo P, et al. Among authors: minnella g.
Am J Hematol. 2022 Nov;97(11):E400-E403. doi: 10.1002/ajh.26697. Epub 2022 Sep 8.
Am J Hematol. 2022.
PMID: 36054600
Free article.
No abstract available.